: Today it is widely recognized that the PD-1/PD-L1 axis plays a fundamental role in escaping the immune system in cancers, so that anti-PD-1/PD-L1 antibodies have been evaluated for their antitumor properties in more than 1000 clinical trials. As a result, some of them have entered the market revolutionizing the treatment landscape of specific cancer types. Nonetheless, a new era based on the development of small molecules as anti PD-L1 drugs has begun. There are, however, some limitations to advancing these compounds into clinical stages including the possible difficulty in counteracting the PD-1/PD-L1 interaction in vivo, the discrepancy between the in vitro IC50 (HTFR assay) and cellular EC50 (immune checkpoint blockade co-culture assay), and the differences in ligands' affinity between human and murine PD-L1, which can affect their preclinical evaluation. Here, an extensive theoretical study, assisted by MicroScale Thermophoresis binding assays and NMR experiments, was performed to provide an atomistic picture of the binding event of three representative biphenyl-based compounds in both human and murine PD-L1. Structural determinants of the species' specificity were unraveled, providing unprecedented details useful for the design of next generation anti-PD-L1 molecules.

Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design / Donati, Greta; D'Amore, Vincenzo Maria; Russomanno, Pasquale; Cerofolini, Linda; Amato, Jussara; Marzano, Simona; Salobehaj, Maria; Rizzo, Domenico; Assoni, Giulia; Carotenuto, Alfonso; La Pietra, Valeria; Arosio, Daniela; Seneci, Pierfausto; Fragai, Marco; Brancaccio, Diego; Di Leva, Francesco Saverio; Marinelli, Luciana. - In: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. - ISSN 2001-0370. - ELETTRONICO. - 21:(2023), pp. 3355-3368. [10.1016/j.csbj.2023.06.006]

Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design

Russomanno, Pasquale;Cerofolini, Linda;Salobehaj, Maria;Rizzo, Domenico;Carotenuto, Alfonso;Fragai, Marco;
2023

Abstract

: Today it is widely recognized that the PD-1/PD-L1 axis plays a fundamental role in escaping the immune system in cancers, so that anti-PD-1/PD-L1 antibodies have been evaluated for their antitumor properties in more than 1000 clinical trials. As a result, some of them have entered the market revolutionizing the treatment landscape of specific cancer types. Nonetheless, a new era based on the development of small molecules as anti PD-L1 drugs has begun. There are, however, some limitations to advancing these compounds into clinical stages including the possible difficulty in counteracting the PD-1/PD-L1 interaction in vivo, the discrepancy between the in vitro IC50 (HTFR assay) and cellular EC50 (immune checkpoint blockade co-culture assay), and the differences in ligands' affinity between human and murine PD-L1, which can affect their preclinical evaluation. Here, an extensive theoretical study, assisted by MicroScale Thermophoresis binding assays and NMR experiments, was performed to provide an atomistic picture of the binding event of three representative biphenyl-based compounds in both human and murine PD-L1. Structural determinants of the species' specificity were unraveled, providing unprecedented details useful for the design of next generation anti-PD-L1 molecules.
2023
21
3355
3368
Donati, Greta; D'Amore, Vincenzo Maria; Russomanno, Pasquale; Cerofolini, Linda; Amato, Jussara; Marzano, Simona; Salobehaj, Maria; Rizzo, Domenico; Assoni, Giulia; Carotenuto, Alfonso; La Pietra, Valeria; Arosio, Daniela; Seneci, Pierfausto; Fragai, Marco; Brancaccio, Diego; Di Leva, Francesco Saverio; Marinelli, Luciana
File in questo prodotto:
File Dimensione Formato  
main.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 10.37 MB
Formato Adobe PDF
10.37 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1320772
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact